Malondialdehyde acetaldehyde adduction of surfactant protein D attenuates SARS-CoV-2 spike protein binding and virus neutralization.
SARS-CoV-2
alcohol
cigarette smoke
lung immunity
malondialdehyde acetaldehyde
surfactant protein D
Journal
Alcohol, clinical & experimental research
ISSN: 2993-7175
Titre abrégé: Alcohol Clin Exp Res (Hoboken)
Pays: United States
ID NLM: 9918609780906676
Informations de publication
Date de publication:
01 2023
01 2023
Historique:
revised:
01
11
2022
received:
30
08
2022
accepted:
06
11
2022
pubmed:
11
11
2022
medline:
25
2
2023
entrez:
10
11
2022
Statut:
ppublish
Résumé
Over 43% of the world's population regularly consumes alcohol. Although not commonly known, alcohol can have a significant impact on the respiratory environment. Living in the time of the COVID-19 pandemic, alcohol misuse can have a particularly deleterious effect on SARS-CoV-2-infected individuals and, in turn, the overall healthcare system. Patients with alcohol use disorders have higher odds of COVID-19-associated hospitalization and mortality. Even though the detrimental role of alcohol on COVID-19 outcomes has been established, the underlying mechanisms are yet to be fully understood. Alcohol misuse has been shown to induce oxidative damage in the lungs through the production of reactive aldehydes such as malondialdehyde and acetaldehyde (MAA). MAA can then form adducts with proteins, altering their structure and function. One such protein is surfactant protein D (SPD), which plays an important role in innate immunity against pathogens. In this study, we examined whether MAA adduction of SPD (SPD-MAA) attenuates the ability of SPD to bind SARS-CoV-2 spike protein, reversing SPD-mediated virus neutralization. Using ELISA, we show that SPD-MAA is unable to competitively bind spike protein and prevent ACE2 receptor binding. Similarly, SPD-MAA fails to inhibit entry of wild-type SARS-CoV-2 virus into Calu-3 cells, a lung epithelial cell line, as well as ciliated primary human bronchial epithelial cells isolated from healthy individuals. Overall, MAA adduction of SPD, a consequence of alcohol overconsumption, represents one mechanism of compromised lung innate defense against SARS-CoV-2, highlighting a possible mechanism underlying COVID-19 severity and related mortality in patients who misuse alcohol.
Sections du résumé
BACKGROUND
Over 43% of the world's population regularly consumes alcohol. Although not commonly known, alcohol can have a significant impact on the respiratory environment. Living in the time of the COVID-19 pandemic, alcohol misuse can have a particularly deleterious effect on SARS-CoV-2-infected individuals and, in turn, the overall healthcare system. Patients with alcohol use disorders have higher odds of COVID-19-associated hospitalization and mortality. Even though the detrimental role of alcohol on COVID-19 outcomes has been established, the underlying mechanisms are yet to be fully understood. Alcohol misuse has been shown to induce oxidative damage in the lungs through the production of reactive aldehydes such as malondialdehyde and acetaldehyde (MAA). MAA can then form adducts with proteins, altering their structure and function. One such protein is surfactant protein D (SPD), which plays an important role in innate immunity against pathogens.
METHODS AND RESULTS
In this study, we examined whether MAA adduction of SPD (SPD-MAA) attenuates the ability of SPD to bind SARS-CoV-2 spike protein, reversing SPD-mediated virus neutralization. Using ELISA, we show that SPD-MAA is unable to competitively bind spike protein and prevent ACE2 receptor binding. Similarly, SPD-MAA fails to inhibit entry of wild-type SARS-CoV-2 virus into Calu-3 cells, a lung epithelial cell line, as well as ciliated primary human bronchial epithelial cells isolated from healthy individuals.
CONCLUSIONS
Overall, MAA adduction of SPD, a consequence of alcohol overconsumption, represents one mechanism of compromised lung innate defense against SARS-CoV-2, highlighting a possible mechanism underlying COVID-19 severity and related mortality in patients who misuse alcohol.
Identifiants
pubmed: 36352814
doi: 10.1111/acer.14974
pmc: PMC9878066
doi:
Substances chimiques
Acetaldehyde
GO1N1ZPR3B
spike protein, SARS-CoV-2
0
Spike Glycoprotein, Coronavirus
0
Pulmonary Surfactant-Associated Protein D
0
Malondialdehyde
4Y8F71G49Q
Ethanol
3K9958V90M
Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
95-103Subventions
Organisme : BLRD VA
ID : I01 BX005413
Pays : United States
Organisme : BLRD VA
ID : IK6 BX003781
Pays : United States
Informations de copyright
© 2022 Research Society on Alcohol.
Références
Ahn, J.H., Kim, J., Hong, S.P., Choi, S.Y., Yang, M.J., Ju, Y.S. et al. (2021) Nasal ciliated cells are primary targets for sars-cov-2 replication in the early stage of covid-19. The Journal of Clinical Investigation, 131, e148517.
Al-Ahdal, M.N., Murugaiah, V., Varghese, P.M., Abozaid, S.M., Saba, I., Al-Qahtani, A.A. et al. (2018) Entry inhibition and modulation of pro-inflammatory immune response against influenza a virus by a recombinant truncated surfactant protein d. Frontiers in Immunology, 9, 1586.
Alberca, R.W., Rigato, P.O., Ramos, Y.A.L., Teixeira, F.M.E., Branco, A.C.C., Fernandes, I.G. et al. (2021) Clinical characteristics and survival analysis in frequent alcohol consumers with covid-19. Frontiers in Nutrition, 8, 689296.
Bailey, K.L., Sayles, H., Campbell, J., Khalid, N., Anglim, M., Ponce, J. et al. (2022) Covid-19 patients with documented alcohol use disorder or alcohol-related complications are more likely to be hospitalized and have higher all-cause mortality. Alcoholism, Clinical and Experimental Research, 46, 1023-1035.
Bailey, K.L., Wyatt, T.A., Katafiasz, D.M., Taylor, K.W., Heires, A.J., Sisson, J.H. et al. (2019) Alcohol and cannabis use alter pulmonary innate immunity. Alcohol, 80, 131-138.
Berger, J.P., Simet, S.M., Devasure, J.M., Boten, J.A., Sweeter, J.M., Kharbanda, K.K. et al. (2014) Malondialdehyde-acetaldehyde (maa) adducted proteins bind to scavenger receptor a in airway epithelial cells. Alcohol, 48, 493-500.
Bhalla, S., Sharma, B., Smith, D., Boley, R., McCluskey, C., Ilyas, Y. et al. (2021) Investigating unhealthy alcohol use as an independent risk factor for increased covid-19 disease severity: observational cross-sectional study. JMIR Public Health and Surveillance, 7, e33022.
Burnham, E.L., McNally, A., Gaydos, J. & Brown, L.A.S. (2016) The relationship between airway antioxidant levels, alcohol use disorders, and cigarette smoking. Alcoholism: Clinical and Experimental Research, 40, 2147-2160.
Calesnick, B. & Vernick, H. (1971) Antitussive activity of ethanol. Quarterly Journal of Studies on Alcohol, 32, 434-441.
Centers for Disease Control and Prevention. (2022) Alcohol use and your health [Online]. Available from: https://www.cdc.gov/alcohol/fact-sheets/alcohol-use.htm [Accessed 8th August 2022]
Crouch, E., Parghi, D., Kuan, S. & Persson, A. (1992) Surfactant protein D: subcellular localization in nonciliated bronchiolar epithelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology, 263, L60-L66.
Crouch, E.C. (2000) Surfactant protein-D and pulmonary host defense. Respiratory Research, 1, 1-16.
de Roux, A., Cavalcanti, M., Marcos, M.A., Garcia, E., Ewig, S., Mensa, J. et al. (2006) Impact of alcohol abuse in the etiology and severity of community-acquired pneumonia. Chest, 129, 1219-1225.
Doyon, W.M., Dong, Y., Ostroumov, A., Thomas, A.M., Zhang, T.A. & Dani, J.A. (2013) Nicotine decreases ethanol-induced dopamine signaling and increases self-administration via stress hormones. Neuron, 79, 530-540.
Esposito, A.J., Menon, A.A., Ghosh, A.J., Putman, R.K., Fredenburgh, L.E., El-Chemaly, S.Y. et al. (2020) Increased odds of death for patients with interstitial lung disease and covid-19: a case-control study. American Journal of Respiratory and Critical Care Medicine, 202, 1710-1713.
Fulcher, M.L., Gabriel, S., Burns, K.A., Yankaskas, J.R. & Randell, S.H. (2005) Well-differentiated human airway epithelial cell cultures. In: Human cell culture protocols. New York City, NY: Springer.
Funk, C.J., Wang, J., Ito, Y., Travanty, E.A., Voelker, D.R., Holmes, K.V. et al. (2012) Infection of human alveolar macrophages by human coronavirus strain 229e. The Journal of General Virology, 93, 494-503.
Ganesh, B., Rajakumar, T., Malathi, M., Manikandan, N., Nagaraj, J., Santhakumar, A. et al. (2021) Epidemiology and pathobiology of SARS-COV-2 (covid-19) in comparison with sars, mers: an updated overview of current knowledge and future perspectives. Clinical Epidemiology and Global Health, 10, 100694.
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X. et al. (2020) Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine, 382, 1708-1720.
Hartshorn, K., Crouch, E.C., White, M.R., Eggleton, P., Tauber, A.I., Chang, D. et al. (1994) Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza a viruses. The Journal of Clinical Investigation, 94, 311-319.
Hartshorn, K.L., Webby, R., White, M.R., Tecle, T., Pan, C., Boucher, S. et al. (2008) Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D. Respiratory Research, 9, 1-12.
Hartshorn, K.L., White, M.R., Voelker, D.R., Coburn, J., Zaner, K. & Crouch, E.C. (2000) Mechanism of binding of surfactant protein D to influenza a viruses: importance of binding to haemagglutinin to antiviral activity. Biochemical Journal, 351, 449-458.
Hillaire, M.L., Haagsman, H.P., Osterhaus, A.D., Rimmelzwaan, G.F. & Van Eijk, M. (2013) Pulmonary surfactant protein d in first-line innate defence against influenza a virus infections. Journal of Innate Immunity, 5, 197-208.
Hsieh, M.H., Beirag, N., Murugaiah, V., Chou, Y.C., Kuo, W.S., Kao, H.F. et al. (2021) Human surfactant protein d binds spike protein and acts as an entry inhibitor of sars-cov-2 pseudotyped viral particles. Frontiers in Immunology, 12, 641360.
Jerrells, T.R., Pavlik, J.A., Devasure, J., Vidlak, D., Costello, A., Strachota, J.M. et al. (2007) Association of chronic alcohol consumption and increased susceptibility to and pathogenic effects of pulmonary infection with respiratory syncytial virus in mice. Alcohol, 41, 357-369.
Kerget, B., Kerget, F., Koçak, A.O., Kızıltunç, A., Araz, Ö., Uçar, E.Y. et al. (2020) Are serum interleukin 6 and surfactant protein d levels associated with the clinical course of covid-19? Lung, 198, 777-784.
Lee, I.T., Nakayama, T., Wu, C.T., Goltsev, Y., Jiang, S., Gall, P.A. et al. (2020) Ace2 localizes to the respiratory cilia and is not increased by ace inhibitors or arbs. Nature Communications, 11, 5453.
Leth-Larsen, R., Zhong, F., Chow, V.T., Holmskov, U. & Lu, J. (2007) The sars coronavirus spike glycoprotein is selectively recognized by lung surfactant protein d and activates macrophages. Immunobiology, 212, 201-211.
Li, F. (2015) Receptor recognition mechanisms of coronaviruses: a decade of structural studies. Journal of Virology, 89, 1954-1964.
Marini, J.J. & Gattinoni, L. (2020) Management of covid-19 respiratory distress. JAMA, 323, 2329-2330.
McCaskill, M.L., Kharbanda, K.K., Tuma, D.J., Reynolds, J.D., Devasure, J.M., Sisson, J.H. et al. (2011) Hybrid malondialdehyde and acetaldehyde protein adducts form in the lungs of mice exposed to alcohol and cigarette smoke. Alcoholism, Clinical and Experimental Research, 35, 1106-1113.
Meschi, J., Crouch, E.C., Skolnik, P., Yahya, K., Holmskov, U., Leth-Larsen, R. et al. (2005) Surfactant protein d binds to human immunodeficiency virus (HIV) envelope protein gp120 and inhibits HIV replication. Journal of General Virology, 86, 3097-3107.
Meyerholz, D.K., Edsen-Moore, M., McGill, J., Coleman, R.A., Cook, R.T. & Legge, K.L. (2008) Chronic alcohol consumption increases the severity of murine influenza virus infections. The Journal of Immunology, 181, 641-648.
Moss, M. & Burnham, E.L. (2003) Chronic alcohol abuse, acute respiratory distress syndrome, and multiple organ dysfunction. Critical Care Medicine, 31, S207-S212.
Moss, M. & Burnham, E.L. (2006) Alcohol abuse in the critically ill patient. The Lancet, 368, 2231-2242.
Moss, M., Parsons, P.E., Steinberg, K.P., Hudson, L.D., Guidot, D.M., Burnham, E.L. et al. (2003) Chronic alcohol abuse is associated with an increased incidence of acute respiratory distress syndrome and severity of multiple organ dysfunction in patients with septic shock. Critical Care Medicine, 31, 869-877.
Mueller, A.L., McNamara, M.S. & Sinclair, D.A. (2020) Why does covid-19 disproportionately affect older people? Aging (Albany NY), 12, 9959-9981.
Nayak, A., Dodagatta-Marri, E., Tsolaki, A.G. & Kishore, U. (2012) An insight into the diverse roles of surfactant proteins, sp-a and sp-d in innate and adaptive immunity. Frontiers in Immunology, 3, 131.
Ng, W.C., Tate, M.D., Brooks, A.G. & Reading, P.C. (2012) Soluble host defense lectins in innate immunity to influenza virus. Journal of Biomedicine and Biotechnology, 2012, 1-14.
Nissen, C.G., Mosley, D.D., Kharbanda, K.K., Katafiasz, D.M., Bailey, K.L. & Wyatt, T.A. (2022) Malondialdehyde acetaldehyde-adduction changes surfactant protein d structure and function. Frontiers in Immunology, 13, 866795.
Pandit, H., Gopal, S., Sonawani, A., Yadav, A.K., Qaseem, A.S., Warke, H. et al. (2014) Surfactant protein d inhibits HIV-1 infection of target cells via interference with gp120-cd4 interaction and modulates pro-inflammatory cytokine production. PLoS One, 9, e102395.
Popkin, B.M., Du, S., Green, W.D., Beck, M.A., Algaith, T., Herbst, C.H. et al. (2020) Individuals with obesity and covid-19: a global perspective on the epidemiology and biological relationships. Obesity Reviews, 21, e13128.
Pranata, R., Soeroto, A., Huang, I., Lim, M., Santoso, P., Permana, H. et al. (2020) Effect of chronic obstructive pulmonary disease and smoking on the outcome of covid-19. The International Journal of Tuberculosis and Lung Disease, 24, 838-843.
Sapkota, M., Burnham, E.L., Devasure, J.M., Sweeter, J.M., Hunter, C.D., Duryee, M.J. et al. (2017) Malondialdehyde-acetaldehyde (MAA) protein adducts are found exclusively in the lungs of smokers with alcohol use disorders and are associated with systemic anti-MAA antibodies. Alcoholism, Clinical and Experimental Research, 41, 2093-2099.
Sapkota, M., Kharbanda, K.K. & Wyatt, T.A. (2016) Malondialdehyde-acetaldehyde-adducted surfactant protein alters macrophage functions through scavenger receptor A. Alcoholism, Clinical and Experimental Research, 40, 2563-2572.
Sapkota, M. & Wyatt, T.A. (2015) Alcohol, aldehydes, adducts and airways. Biomolecules, 5, 2987-3008.
Seeman, J.I., Dixon, M. & Haussmann, H.-J. (2002) Acetaldehyde in mainstream tobacco smoke: formation and occurrence in smoke and bioavailability in the smoker. Chemical Research in Toxicology, 15, 1331-1350.
Sisson, J.H., Wyatt, T.A., Guidot, D.M., Bagby, G.J., Helander, A., Tønnesen, H. et al. (2005) Bench to bedside: mechanisms and consequences of alcohol-altered host defenses. Alcoholism: Clinical and Experimental Research, 29, 1090-1097.
Strong, P., Kishore, U., Morgan, C., Bernal, A.L., Singh, M. & Reid, K.B. (1998) A novel method of purifying lung surfactant proteins A and D from the lung lavage of alveolar proteinosis patients and from pooled amniotic fluid. Journal of Immunological Methods, 220, 139-149.
TenHoor, T., Mannino, D.M. & Moss, M. (2001) Risk factors for ARDS in the United States: analysis of the 1993 national mortality followback study. Chest, 119, 1179-1184.
Tuma, D.J., Thiele, G.M., Xu, D., Klassen, L.W. & Sorrell, M.F. (1996) Acetaldehyde and malondialdehyde react together to generate distinct protein adducts in the liver during long-term ethanol administration. Hepatology, 23, 872-880.
Voorhout, W., Veenendaal, T., Kuroki, Y., Ogasawara, Y., Van Golde, L. & Geuze, H. (1992) Immunocytochemical localization of surfactant protein D (sp-d) in type II cells, Clara cells, and alveolar macrophages of rat lung. Journal of Histochemistry and Cytochemistry, 40, 1589-1597.
Wan, Y., Graham, R., Baric, R. & Li, F. (2020) An analysis based on decade-long structural studies of SARS 3, JVI accepted manuscript posted online 29 January 2020. Journal of Virology, 94, e00127-e00120.
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J. et al. (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 323, 1061-1069.
Warren, K.J., Poole, J.A., Sweeter, J.M., Devasure, J.M. & Wyatt, T.A. (2019) An association between MMP-9 and impaired T cell migration in ethanol-fed BALB/C mice infected with respiratory syncytial virus-2A. Alcohol, 80, 25-32.
Warren, K.J., Simet, S.M., Pavlik, J.A., Devasure, J.M., Sisson, J.H., Poole, J.A. et al. (2016) RSV-specific anti-viral immunity is disrupted by chronic ethanol consumption. Alcohol, 55, 35-42.
World Health Organization. (2019) Global status report on alcohol and health 2018. Geneva: World Health Organization.
World Health Organization. (2022) Who coronavirus (covid-19) dashboard [Online]. Available from: https://covid19.who.int [Accessed 8th August 2022]
Wu, D. & Cederbaum, A.I. (2003) Alcohol, oxidative stress, and free radical damage. Alcohol Research & Health, 27, 277-284.
Wu, J.T., Leung, K., Bushman, M., Kishore, N., Niehus, R., De Salazar, P.M. et al. (2020) Estimating clinical severity of covid-19 from the transmission dynamics in Wuhan, China. Nature Medicine, 26, 506-510.
Wu, Y., Liu, Z., Wei, R., Pan, S., Mao, N., Chen, B. et al. (2009) Elevated plasma surfactant protein D (SP-D) levels and a direct correlation with anti-severe acute respiratory syndrome coronavirus-specific igg antibody in SARS patients. Scandinavian Journal of Immunology, 69, 508-515.
Wyatt, T.A., Kharbanda, K.K., McCaskill, M.L., Tuma, D.J., Yanov, D., Devasure, J. et al. (2012) Malondialdehyde-acetaldehyde-adducted protein inhalation causes lung injury. Alcohol (Fayetteville, NY), 46, 51-59.
Wyatt, T.A., Warren, K.J., Wetzel, T.J., Suwondo, T., Rensch, G.P., Devasure, J.M. et al. (2021) Malondialdehyde-acetaldehyde adduct formation decreases immunoglobulin a transport across airway epithelium in smokers who abuse alcohol. The American Journal of Pathology, 191, 1732-1742.
Yang, L., Liu, S., Liu, J., Zhang, Z., Wan, X., Huang, B. et al. (2020) Covid-19: immunopathogenesis and immunotherapeutics. Signal Transduction and Targeted Therapy, 5, 1-8.
Yeligar, S.M., Chen, M.M., Kovacs, E.J., Sisson, J.H., Burnham, E.L. & Brown, L.A. (2016) Alcohol and lung injury and immunity. Alcohol, 55, 51-59.
Yi, Y., Lagniton, P.N., Ye, S., Li, E. & Xu, R.-H. (2020) Covid-19: what has been learned and to be learned about the novel coronavirus disease. International Journal of Biological Sciences, 16, 1753-1766.